Analytical Characterization of Pneumococcal Vaccine Conjugates Using SEC-MALS Technique

Area of Science:

• Vaccinology
• Analytical Chemistry
• Biophysical Characterization

Background:

• Streptococcus pneumoniae infections cause severe illness, necessitating effective conjugate vaccines.
• Developing pneumococcal conjugate vaccines requires detailed characterization of polysaccharide and protein components.
• Existing analytical methods may not fully capture the complexity of conjugate vaccine structures.

Purpose of the Study:

• To demonstrate the utility of size-exclusion chromatography-multi-angle light scattering (SEC-MALS) for pneumococcal conjugate vaccine characterization.
• To evaluate SEC-MALS for assessing key attributes like molecular weight, composition, and conjugation efficiency.
• To showcase SEC-MALS as a tool for optimizing vaccine development and manufacturing.

Main Methods:

• Utilized SEC-MALS to analyze pneumococcal conjugate vaccines.
• Employed specific capsular polysaccharides (STs 1, 3, 5, 10A, 18C, 24F, 33F) conjugated to rCRM197 carrier protein.
• Validated the technique using established standards for accuracy and repeatability.

Main Results:

• SEC-MALS demonstrated high accuracy (>90%) and repeatability (<2% RSD) for molar mass measurements.
• The technique provided detailed information on conjugate molecular assembly and conformation.
• Compositional analysis enabled refinement of the conjugation process to achieve desired molar masses.

Conclusions:

• SEC-MALS is a valuable tool for in-depth biophysical characterization of conjugate vaccines.
• Accurate characterization is crucial for optimizing vaccine product attributes and ensuring manufacturing consistency.
• This technique supports the development of potent and reliable pneumococcal conjugate vaccines.